Richmond Hill, Canada Clinical Trials

A listing of Richmond Hill, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 49 clinical trials
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease. Additional participants will be enrolled to an addendum safety cohort. The participants will be administered open-label donanemab.

alzheimer's disease
mini-mental state examination
flortaucipir
positron emission tomography
florbetapir
Toronto Memory Program
 (9.6 away) Contact site
  • 92 views
  • 26 Sep, 2021
  • +394 other locations
A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA2)

This is a multi-center Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning that some patients entering the study will not receive active study …

areata alopecia
The Centre for Dermatology
 (3.5 away) Contact site
  • 3 views
  • 21 Sep, 2021
  • +61 other locations
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

The purpose of this study is to evaluate the effectiveness and safety of 3 dose regimen of CC-93538 in adult participants with moderate to severe Atopic Dermatitis (AD).

corticosteroids
topical agents
asthma
ultraviolet light
montelukast
Lynderm Research Inc
 (8.9 away) Contact site
  • 1 views
  • 18 Sep, 2021
  • +90 other locations
An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

This is a clinical study in adult participants with moderate to severe atopic dermatitis (AD). The purpose of the study is to test a new medicine (LEO 138559) given by injection to see if it works to treat AD and what the side effects are when compared with a placebo …

eczema
topical agents
LEO Investigational Site
 (9.0 away) Contact site
  • 4 views
  • 23 Sep, 2021
  • +10 other locations
Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes

This study compares three doses of once daily semaglutide tablets in people with type 2 diabetes who were previously treated with other oral anti-diabetic medicines. Participants will be initiated on the lowest starting dose of 3 mg and gradually increased until they reach the final trial dose of 14 mg, …

Novo Nordisk Investigational Site
 (6.8 away) Contact site
  • 30 views
  • 19 Sep, 2021
  • +155 other locations
Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer

This is a Global Study of Neoadjuvant-Adjuvant Durvalumab or Placebo and FLOT Chemotherapy Followed by Adjuvant Durvalumab or Placebo in Patients with Resectable Gastric and Gastroesophageal Cancer (GC/GEJC) (MATTERHORN).

oxaliplatin
immunoglobulin
adenocarcinoma
cancer
monoclonal antibodies
Research Site
 (8.7 away) Contact site
  • 0 views
  • 15 Sep, 2021
  • +153 other locations
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disease.

amyloidosis
alzheimer's disease
mini-mental state examination
Toronto Memory Clinic
 (9.6 away) Contact site
  • 0 views
  • 22 Sep, 2021
  • +85 other locations
A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA1)

This is a multi-center Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning that some patients entering the study will not receive active study …

areata alopecia
Lynderm Research Inc.
 (8.7 away) Contact site
  • 33 views
  • 19 Sep, 2021
  • +77 other locations
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)

bimekizumab
antibiotics
abscess
hidradenitis
Hs0003 50233
 (37.0 away) Contact site
  • 303 views
  • 26 Sep, 2021
  • +94 other locations
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

The study aims to evaluate two, orally administered, investigational agents - PF-06865571 (DGAT2 inhibitor) and the coadministration of PF-06865571 with PF-05221304 (ACC inhibitor). This study is specifically designed to evaluate the effect of a range of doses of DGAT2i alone, and DGAT2i + ACCi, on resolution of NASH or improvement …

hepatic fibrosis
steatohepatitis
fibrosis
LMC Clinical Research Inc. (Thornhill)
 (6.8 away) Contact site
  • 72 views
  • 26 Sep, 2021
  • +350 other locations